Latest Stories

Don’t miss our hot and upcoming stories
Could Proprio’s FDA-Cleared AI Platform Redefine Surgical Precision for 1,000+ Spine Centers Globally?

Key Highlights for Executives and Innovators First-Ever FDA Clearance for Real-Time Intraoperative MeasurementProprio’s Paradigm platform…

ByByAnuja SinghMay 30, 2025
What Could Tempus and Boehringer Ingelheim’s Multi-Year AI Collaboration Mean for the Future of Cancer Drug Development?

Key Takeaways for Executives and Industry Leaders Tempus expands AI reach with a leading pharma…

ByByAnuja SinghMay 29, 2025
What Does the Tempus–Verastem CDx Collaboration Mean for the Future of AI-Driven Precision Oncology and FDA Approvals?

Key Highlights: FDA milestone: a new era for targeted LGSOC therapiesTempus AI and Verastem Oncology…

ByByAnuja SinghMay 29, 2025
Is the Devano and Verge Genomics AI Collaboration the Next Big Leap in Biomedical Data Curation and Drug Discovery?

Key Executive Takeaways Transforming Drug Discovery Through AI-Driven Data IntegrationVerge Genomics, a clinical-stage biotech innovator,…

ByByAnuja SinghMay 29, 2025
Scroll to Top